内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

糖尿病人群基线高敏C反应蛋白3.0mg/L新发心脑血管事件风险高

2012-08-07 晓静 摘编 医学论坛网

高敏C反应蛋白高血压糖尿病心脑血管事件
关注

　　河北联合大学附属开滦医院与河北遵化市人民医院和唐山市第三医院联合研究发现，基线高敏C反应蛋白(hsC-RP)>3.0mg/L增加无高血压病史的糖尿病人群新发心脑血管事件的风险。 相关论文发表于2012年第6期《中国糖尿病杂志》。 　　研究者们采用前瞻性队列研究方法,以参加健康体检的101510名开滦集团职工中FPG≥7.0mmol/L或已确诊为糖尿病,正在使用降糖药物的297

　　河北联合大学附属开滦医院与河北遵化市人民医院和唐山市第三医院联合研究发现，基线高敏C反应蛋白(hsC-RP)>3.0mg/L增加无高血压病史的糖尿病人群新发心脑血管事件的风险。 相关论文发表于2012年第6期《中国糖尿病杂志》。

　　研究者们采用前瞻性队列研究方法,以参加健康体检的101510名开滦集团职工中FPG≥7.0mmol/L或已确诊为糖尿病,正在使用降糖药物的2973例糖尿病患者作为观察队列,平均随访(47.26±5.38)个月。

　　结果显示，基线hsC-RP水平增高,心脑血管事件发生率、死亡率、全因死亡率增高(P<0.05)。Cox风险模型表明,hsC-RP>3.0mg/L者发生心脑血管事件、心脑血管死亡、全因死亡的风险分别是hsC-RP≤3.0mg/L者的1.63倍(95%CI:1.03～2.57)、2.62倍(95%CI:1.12～6.12)和1.73倍(95%CI:1.06～2.84)。

　

    

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643296, encodeId=a8111643296ec, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Mar 01 14:15:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297801, encodeId=9db5129e80148, content=<a href='/topic/show?id=4eca5598c7' target=_blank style='color:#2F92EE;'>#C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5598, encryptionId=4eca5598c7, topicName=C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580997, encodeId=4277158099e8d, content=<a href='/topic/show?id=03d051e14e5' target=_blank style='color:#2F92EE;'>#心脑血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51714, encryptionId=03d051e14e5, topicName=心脑血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aec16671813, createdName=1508842480_96220442, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614809, encodeId=1beb161480931, content=<a href='/topic/show?id=49d810240513' target=_blank style='color:#2F92EE;'>#高敏C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102405, encryptionId=49d810240513, topicName=高敏C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa19545213, createdName=1249884fm93暂无昵称, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=)]
    2013-03-01 hukaixun

    #血管事件#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1643296, encodeId=a8111643296ec, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Mar 01 14:15:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297801, encodeId=9db5129e80148, content=<a href='/topic/show?id=4eca5598c7' target=_blank style='color:#2F92EE;'>#C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5598, encryptionId=4eca5598c7, topicName=C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580997, encodeId=4277158099e8d, content=<a href='/topic/show?id=03d051e14e5' target=_blank style='color:#2F92EE;'>#心脑血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51714, encryptionId=03d051e14e5, topicName=心脑血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aec16671813, createdName=1508842480_96220442, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614809, encodeId=1beb161480931, content=<a href='/topic/show?id=49d810240513' target=_blank style='color:#2F92EE;'>#高敏C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102405, encryptionId=49d810240513, topicName=高敏C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa19545213, createdName=1249884fm93暂无昵称, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=)]
    2012-08-09 JR19860219

    #C反应蛋白#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1643296, encodeId=a8111643296ec, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Mar 01 14:15:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297801, encodeId=9db5129e80148, content=<a href='/topic/show?id=4eca5598c7' target=_blank style='color:#2F92EE;'>#C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5598, encryptionId=4eca5598c7, topicName=C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580997, encodeId=4277158099e8d, content=<a href='/topic/show?id=03d051e14e5' target=_blank style='color:#2F92EE;'>#心脑血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51714, encryptionId=03d051e14e5, topicName=心脑血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aec16671813, createdName=1508842480_96220442, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614809, encodeId=1beb161480931, content=<a href='/topic/show?id=49d810240513' target=_blank style='color:#2F92EE;'>#高敏C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102405, encryptionId=49d810240513, topicName=高敏C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa19545213, createdName=1249884fm93暂无昵称, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=)]
    2012-08-09 1508842480_96220442

    #心脑血管事件#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1643296, encodeId=a8111643296ec, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Mar 01 14:15:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297801, encodeId=9db5129e80148, content=<a href='/topic/show?id=4eca5598c7' target=_blank style='color:#2F92EE;'>#C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5598, encryptionId=4eca5598c7, topicName=C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580997, encodeId=4277158099e8d, content=<a href='/topic/show?id=03d051e14e5' target=_blank style='color:#2F92EE;'>#心脑血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51714, encryptionId=03d051e14e5, topicName=心脑血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aec16671813, createdName=1508842480_96220442, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614809, encodeId=1beb161480931, content=<a href='/topic/show?id=49d810240513' target=_blank style='color:#2F92EE;'>#高敏C反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102405, encryptionId=49d810240513, topicName=高敏C反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa19545213, createdName=1249884fm93暂无昵称, createdTime=Thu Aug 09 05:15:00 CST 2012, time=2012-08-09, status=1, ipAttribution=)]
    2012-08-09 1249884fm93暂无昵称

    #高敏C反应蛋白#

    0